Brief: Can-Fite Provides Update On Clinical And Financial Status
16/12/2025 15:16
Dec 16 (Reuters) - Can Fite Biopharma Ltd CANF.TA: CAN-FITE PROVIDES UPDATE ON CLINICAL AND FINANCIAL STATUS Source text: ID:nGNX20ZGwm Further company coverage: CANF.TA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Following Positive Phase 2A Pancreatic Cancer Data, Can-Fite Advances Namodenoson Into Phase 2B Combination Study With Immunotherapy
Can-Fite Biopharma surges as pancreatic cancer drug meets main goal in study
Brief: Can-Fite Completes Patient Enrollment In Phase 2A Pancreatic Cancer Study Of Namodenoson
Board Approved A 1-For-3,000 Reverse Split Of Company's Ordinary Shares
Brief: Can-Fite Provides Update On Clinical And Financial Status